㰀栀琀洀氀㸀
㰀氀椀渀欀 爀攀氀㴀∀猀琀礀氀攀猀栀攀攀琀∀ 琀礀瀀攀㴀∀琀攀砀琀⼀挀猀猀∀ 栀爀攀昀㴀∀猀琀礀氀攀⸀挀猀猀∀⼀㸀
㰀戀漀搀礀㸀
Centre de Référence des Rhumatismes Inflammatoires et Maladies Autoimmunes Systémiques Rares de l’Enfant (RAISE) / 2017
65
onset spondylarthropathies. Ann
Rheum Dis, 2002, 61 : 941-2
Céspedes-Cruz
Loy
A,
Murray
KJ,
Methotrexate
health-related
Foster
LR,
British Society for Paediatric and
Adolescent
Autologous
Rheumatology.
haematopoeitic
stem
severe
rheumatic
disease
members--executive
summary.
Rheumatology
(Oxford).
Dec;45(12):1570–1.
2006
García-Carrasco
M,
Alexandro
RO,
Rojas-Rodriguez J, Escobar LE.
Efficacy
systemic
of
thalidomide
Bone
Spine. 2007 Oct;74(5):500–3.
Gattorno
Lasigliè
D, Tassi S, Brisca G, Carta S, et al.
anti-interleukin-1
treatment
distinguishes
patients
juvenile
Arthritis
with
idiopathic
Rheum.
May;58(5):1505–15.
Gerloni
Gattinara
M, Arnoldi C, Pontikaki I, Fantini F.
of
cyclosporin A in the treatment of
juvenile
chronic
prospective
study.
Rheumatology (Oxford). 2001
Aug;40(8):907–13.
Haapasaari
Hakala
M.
antirheumatic drug therapy in
the
treatment
of
Rheumatol.
Apr;20(2):259.
2002
Horneff
Foeldvari
De
Safety
efficacy
to
idiopathic
preliminary
arthritis
(JIA):
data
Rheum
2009
Horneff G, Burgos-Vargas R,
Constantin
Rheum
Dis.
;73(6):1114-22.
4.
Horneff G, Fitter S, Foeldvari I et al Double-blind, placebo-
Ther.
24;14(5):R230